Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2005
04/14/2005US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators
04/14/2005DE10342570A1 Verfahren zur Herstellung von 4-(4-Aminophenyl)-3-morpholinon Process for the preparation of 4- (4-aminophenyl) -3-morpholinone
04/14/2005CA2541299A1 Amide compounds as ion channel ligands and uses thereof
04/14/2005CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
04/14/2005CA2537791A1 Novel amidine compounds for treating microbial infections
04/14/2005CA2537486A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/13/2005EP1522540A1 Azaarene derivatives
04/13/2005EP1521746A1 Quinazolinone modulators of nuclear receptors
04/13/2005EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists
04/13/2005EP1521742A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
04/13/2005EP1521582A1 2,5-substituted pyrimidine derivatives as ccr-3 receptor antagonists
04/13/2005EP1289955B1 Piperidines for use as orexin receptor antagonists
04/13/2005EP1077938B1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives
04/13/2005EP0880507B1 Quinazoline derivatives as antitumor agents
04/13/2005CN1606555A Imidazoquinoline derivatives
04/13/2005CN1606554A Beta-lactamyl vasopressin v1aantagonists
04/13/2005CN1606553A Oxytocin agonistenoxytocin agonisten
04/13/2005CN1606439A Cis-imidazolines
04/13/2005CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents
04/13/2005CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV
04/13/2005CN1196696C New thiochromane derivatives and use as thrombin inhibitors
04/13/2005CN1196694C Polymerisable, optically active dioxolane diesters
04/13/2005CN1196692C Substituted benzopyran derivatives for the treatment of inflammation
04/13/2005CN1196485C Compositions for use against parasitic protozoa
04/12/2005US6878834 Selectively reduced to the corresponding hydroxy group
04/12/2005US6878833 Tetraalkylammonium alkoxides
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878742 Alzheimer's disease; Down's syndrome
04/12/2005US6878739 Composition for treating or preventing glomerulopathy
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/12/2005US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
04/12/2005US6878709 Treating acute and chronic inflammatory disorders and cancer.
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005CA2142445C Injection solutions of azosemide which are ready for injection
04/12/2005CA2081836C Aromatic amidine derivatives and salts thereof
04/07/2005WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005WO2005030765A1 Quinazoline derivatives as antiproliferative agents
04/07/2005WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030757A1 Quinazoline derivatives
04/07/2005WO2005030755A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
04/07/2005WO2005030754A1 Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity
04/07/2005WO2005030750A1 Substituted naphthyl benzothiophene acids
04/07/2005WO2005030749A1 Calcilytic compounds
04/07/2005WO2005030735A1 Triazines derivatives as cell adhesion inhibitors
04/07/2005WO2005030734A1 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (ghs-r) antagonists
04/07/2005WO2005030731A1 Gamma-secretase inhibitors
04/07/2005WO2005030729A1 Isoquinoline potassium channel inhibitors
04/07/2005WO2005030717A1 Substituted indole acid derivatives and their use as pai-1 inhibitors
04/07/2005WO2005030716A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1
04/07/2005WO2005030706A1 Amide type carboxamide derivative
04/07/2005WO2005030705A1 Inhibitors of histone deacetylase
04/07/2005WO2005030704A1 Inhibitors of histone deacetylase
04/07/2005WO2005030216A1 5-arylpyrimidines as anticancer agents
04/07/2005WO2005030209A1 Pyridine derivatives and use thereof as urotensin ii antagonists
04/07/2005WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
04/07/2005WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
04/07/2005WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/07/2005WO2004112719A3 Chemical compounds
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075512 Diamine derivatives, process for producing the same, and bactericide containing the same as active ingredient
04/07/2005US20050075390 HIV protease inhibitors
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075366 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
04/07/2005US20050075357 5-arylpyrimidines as anticancer agents
04/07/2005US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS
04/07/2005US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage
04/07/2005US20050075346 Novel compounds
04/07/2005US20050075344 Melanocortin receptor agonists
04/07/2005US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/07/2005US20050075330 Dipeptidyl peptidase inhibitors
04/07/2005US20050075327 Carbamic acid alkyl ester derivatives
04/07/2005US20050075320 Gamma-secretase inhibitors
04/07/2005US20050075269 Substituted benzofuran-2-carboxamides derivatives
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/07/2005DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use
04/07/2005CA2540031A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005CA2540019A1 Quinazoline derivatives as antiproliferative agents
04/07/2005CA2540008A1 Quinazoline derivatives
04/07/2005CA2539235A1 5-arylpyrimidines as anticancer agents
04/07/2005CA2539117A1 Inhibitors of histone deacetylase
04/07/2005CA2539042A1 Gamma-secretase inhibitors
04/07/2005CA2538703A1 Substituted indole acid derivatives and their use as pai-1 inhibitors
04/07/2005CA2538694A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1
04/07/2005CA2538354A1 Substituted naphthyl benzothiophene acids
04/06/2005EP1520856A1 Androgen receptor agonist
04/06/2005EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone
04/06/2005EP1520472A2 Herbicidal compositions comprising pyridoyl-1,3-cyclodiones
04/06/2005EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers
04/06/2005EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions
04/06/2005EP1520305A2 Charge transport compositions and electronic devices made with such compositions
04/06/2005EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives
04/06/2005EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1414817B1 substituted isoindoles and the use thereof
04/06/2005EP1218357B1 Quinazoline derivatives
04/06/2005EP1202975B1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade